Literature DB >> 7980420

Cysteine-524 is not the only residue involved in the formation of disulphide-bonded dimers of the insulin receptor.

S L Macaulay1, M Polites, D R Hewish, C W Ward.   

Abstract

The human insulin receptor (hIR) is a member of the transmembrane tyrosine kinase receptor family. It is a disulphide-linked homodimer which can be reduced to two insulin-binding monomers by mild reduction of class-I disulphide bonds. The number of disulphide bonds between the alpha- and beta-chains within the monomer or between the monomers in the dimer is not known, although one dimer bond involving hIR Cys-524 has recently been identified [Schaffer and Ljungqvist (1992) Biochem. Biophys. Res. Commun. 189, 650-653]. In the present report hIR Cys-524 was converted into alanine by site-directed mutagenesis and expressed at high levels in Chinese hamster ovary (CHO) cells. The mutant receptor was processed normally and shown to bind insulin normally, with ED50 and KD values not different from those of the wild-type hIR. It was still a disulphide-linked dimer as judged by SDS/PAGE, indicating that there are alpha-alpha-chain disulphide bonds additional to the Cys-524 linkage in the insulin receptor dimer. Insulin-stimulated receptor autophosphorylation and kinase activity of the mutated receptor were both impaired compared with that of the wild-type receptor by 49% and 53% respectively. CHO cells overexpressing the mutant receptor, however, did not show a reduced capacity to stimulate glucose utilization, indicative that the level of receptor expression was sufficient to saturate downstream insulin action. These findings indicate that alpha-alpha disulphides additional to that provided by Cys-524 hold the receptor dimer together and that mutagenesis of Cys-524 reduces the ability of the receptor to signal insulin action subsequent to hormone binding.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980420      PMCID: PMC1137366          DOI: 10.1042/bj3030575

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  The monomeric alpha beta form of the insulin receptor exhibits much higher insulin-dependent tyrosine-specific protein kinase activity than the intact alpha 2 beta 2 form of the receptor.

Authors:  Y Fujita-Yamaguchi; S Kathuria
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

2.  Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor.

Authors:  M A Soos; K Siddle; M D Baron; J M Heward; J P Luzio; J Bellatin; E S Lennox
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

3.  The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling.

Authors:  Y Ebina; L Ellis; K Jarnagin; M Edery; L Graf; E Clauser; J H Ou; F Masiarz; Y W Kan; I D Goldfine
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

4.  A monoclonal antibody to human insulin receptor.

Authors:  F C Kull; S Jacobs; Y F Su; P Cuatrecasas
Journal:  Biochem Biophys Res Commun       Date:  1982-06-15       Impact factor: 3.575

5.  Electrophoretic resolution of three major insulin receptor structures with unique subunit stoichiometries.

Authors:  J Massague; P F Pilch; M P Czech
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

6.  A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor.

Authors:  H Riedel; T J Dull; J Schlessinger; A Ullrich
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

7.  Alteration of intramolecular disulfides in insulin receptor/kinase by insulin and dithiothreitol: insulin potentiates the apparent dithiothreitol-dependent subunit reduction of insulin receptor.

Authors:  P A Wilden; T R Boyle; M L Swanson; L J Sweet; J E Pessin
Journal:  Biochemistry       Date:  1986-07-29       Impact factor: 3.162

8.  On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors.

Authors:  M Bajaj; M D Waterfield; J Schlessinger; W R Taylor; T Blundell
Journal:  Biochim Biophys Acta       Date:  1987-11-26

9.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

10.  Tryptic activation of the insulin receptor. Proteolytic truncation of the alpha-subunit releases the beta-subunit from inhibitory control.

Authors:  S E Shoelson; M F White; C R Kahn
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

View more
  4 in total

Review 1.  The three dimensional structure of the type I insulin-like growth factor receptor.

Authors:  C W Ward; T P Garrett; N M McKern; M Lou; L J Cosgrove; L G Sparrow; M J Frenkel; P A Hoyne; T C Elleman; T E Adams; G O Lovrecz; L J Lawrence; P A Tulloch
Journal:  Mol Pathol       Date:  2001-06

2.  Identification of the cysteine residues involved in the class I disulfide bonds of the human insulin receptor: properties of insulin receptor monomers.

Authors:  K Lu; G Guidotti
Journal:  Mol Biol Cell       Date:  1996-05       Impact factor: 4.138

3.  Structural analysis of natriuretic peptide receptor-C by truncation and site-directed mutagenesis.

Authors:  M Itakura; H Suzuki; S Hirose
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

4.  Mutagenic structure/function analysis of the cytoplasmic cysteines of the insulin receptor.

Authors:  S L Macaulay; M Polites; M J Frenkel; D R Hewish; C W Ward
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.